Describes the therapeutic effect of samarium 153-ethylenediaminetetramethylene phosphonate in an orthotopic human osteosarcoma tibial tumor model. Targeting of potent cytotoxic substances selectively to tumor cells; Preclinical testing of therapeutic modalities; Cell response to therapy with ifosfamide.